Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
Executive Decision Statement Decision: I will initiate an immediate voluntary safety update and regulatory disclosure. I will reject the legal team's "6-month delay" strategy and the board's "wait for data" directive. Delaying disclosure of a known, serious safety signal constitutes fraud in many jurisdictions.Read the full answer